http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2014111079-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2602-10 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C211-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-096 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C211-29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D319-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C317-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C235-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C215-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C217-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C217-58 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 |
| filingDate | 2012-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2014111079-A |
| titleOfInvention | COMPOSITIONS AND METHODS FOR TREATING A NEURODEGENERATIVE DISEASE |
| abstract | 1. The compound of formula I: where R and R are independently selected from H, OH, halogen, C-alkoxy, C-haloalkyl, C-haloalkoxy, (R) (R) N-Ci-alkylene-O-, or R and R are connected to form the - O-ethylene-O-, where R and R independently represent C-alkyl or benzyl, or R and R together with the nitrogen atom form a ring selected from where X represents N or O, and R represents H or unsubstituted phenyl; where at least one of R and R is not H; R is selected from where R, R, R, R and R are independently selected from H, halogen, C-alkyl, C-alkoxy, C-haloalkyl and S (O) -C-alkyl; R represents by itself H; and n is 1-4; R 1 represents C 1-6 alkyl; R 1 represents H or C 1-6 alkyl; and R is H, C-alkyl and C (O) O (C-alkyl), C (O) (C-alkyl) or C (O) (C-haloalkyl); or R and R together with a nitrogen atom form a ring selected from where R and R are independently selected from H, halogen and C-haloalkyl, and Y represents CH or N; R represents H, C 1-6 alkyl, C-cycloalkyl, unsubstituted phenyl or phenyl substituted with C-haloalkyl, or unsubstituted benzyl; R and R are independently selected from H and halogen; R is H and its pharmaceutically acceptable salts, with the exception of the following racemic mixtures of compounds: and 2. A compound according to claim 1, characterized in that: R and R are independently selected from H, OH, halogen, C-alkoxy, C-haloalkyl, C-haloalkoxy, (R) (R) N-Ci-alkylene-O-, or R1 and R2 is connected to form an —O-ethylene-O- group, where R and R are independently C 1-6 alkyl or benzyl, or R and R together with a nitrogen atom form a ring selected from, where X is N or O and R is absent or is H or unsubstituted phenyl ; where at least one of R and R is not H; R |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2692258-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2792562-C2 |
| priorityDate | 2011-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 47.